Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-20 Horowitz Bruce COO Option exercise · 8% Secured Convertible Promissory Notes due 2021 −0 0
2021-06-20 Horowitz Bruce COO Option exercise · Series D-1 Convertible Preferred Stock +38,473 38,473
2021-06-17 Raines Heather CFO Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0
2021-06-17 Bailey Webster Director Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0
2021-06-17 Pershing Edward Director Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0
2021-06-17 WACHTER ERIC PHD CTO Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0
2021-06-17 Horowitz Bruce COO Grant or award · 8% Secured Convertible Promissory Notes due 2021 +0
2020-11-10 Raines Heather CFO Grant or award +50,000 1,213,153
2020-11-10 Lacy John III Director Grant or award +100,000 200,000
2020-11-10 Lacy John III Director Grant or award · Stock Options (Right to Buy) +100,000 100,000
2020-11-10 Horowitz Bruce Chief Operating Officer Grant or award +800,000 2,227,243
2020-11-10 Horowitz Bruce Chief Operating Officer Grant or award · Stock Options (Right to Buy) +2,425,000 2,425,000
2019-03-25 Raines Heather Chief Financial Officer Grant or award +50,000 1,163,153
2017-12-14 Glass John R See Remarks Purchase +84,100 $0.05 $5K 84,100
2017-12-14 Glass John R See Remarks Purchase +115,900 $0.05 $6K 200,000
2016-03-29 CULPEPPER PETER R Interim CEO, CFO, COO Other acquisition +133,333 $1.00 $133K 1,384,496
2016-03-29 CULPEPPER PETER R Interim CEO, CFO, COO Other acquisition +27,333 $1.00 $27K 1,411,829
2016-03-29 CULPEPPER PETER R Interim CEO, CFO, COO Other acquisition +106,000 $1.00 $106K 296,503
2016-03-29 CULPEPPER PETER R Interim CEO, CFO, COO Other disposition · Common Stock Warrants (right to buy) −133,333 0
2016-03-29 CULPEPPER PETER R Interim CEO, CFO, COO Other acquisition · Common Stock Warrants (right to buy) +133,333 133,333

Page 13 of 17 · 329 trades